Showing results (2131-2140 of 4,565) with videos related to

Sort By:
Pageof 457
Advances in Therapy|April 25, 2025
LDL-C Reduction with Evolocumab Among Patients with ASCVD in China: Real-World Evidence from Tianjin Metropolitan AreaLiming Zhao, Jiamei Liu, Yin Liu, et al.
Advances in Therapy|March 27, 2025
Fertility Outcomes in Risdiplam-Treated Male Patients with Spinal Muscular Atrophy: A Multicenter Case SeriesShelley Coskery, Marcus Erdler, Margaret R Frey, et al.
Advances in Therapy|March 28, 2025
Loncastuximab Tesirine Versus Polatuzumab Vedotin Plus Bendamustine and Rituximab in Relapsed/Refractory DLBCL After ≥ 2 Lines of Therapy: Matching-Adjusted Indirect ComparisonKoo Wilson, Francesca Chiodi, Abby Paine, et al.
Advances in Therapy|March 28, 2025
Healthcare Utilization and Costs of Care in Patients With Irritable Bowel Syndrome With Constipation or Chronic Idiopathic Constipation After Initiating Oral Therapies: Real-World Analysis in the US Medicare PopulationEric Shah, Tsung-Ying Lee, Zachary Baldwin, et al.
Advances in Therapy|April 15, 2025
Lidocaine-A Promising Candidate for the Treatment of Cancer-Induced Bone Pain: A Narrative ReviewLihan Luo, Yuqi Cheng, Hanxi Wang, et al.
Advances in Therapy|April 15, 2025
A Phase I Study Comparing the Pharmacokinetics, Safety, and Immunogenicity of A140 Injection and Cetuximab (Erbitux®) in Healthy Chinese Male SubjectsJia Xu, Junyou Ge, Yaling Li, et al.
Advances in Therapy|March 19, 2025
A Noninterventional, Cross-Sectional Study to Assess Patient Prostate Cancer Treatment Preferences and Experiences in EuropeEmmanuelle Kaltenbach, Ana Maria Rodriguez-Leboeuf, Patrick Cabri, et al.
Advances in Therapy|March 18, 2025
Targeting PACAP: Beyond Migraine to Cluster, Menstrual, and Post-traumatic HeadachesLanfranco Pellesi, Mona Ameri Chalmer, Song Guo, et al.
Advances in Therapy|March 19, 2025
An Up-to-Date Description of the Use of Non-steroidal Anti-inflammatory Drugs (NSAIDs) in Italy: Evidence from Real Clinical PracticeValentina Perrone, Chiara Veronesi, Maria Ciappetta, et al.
Advances in Therapy|March 13, 2025
First-Line Tislelizumab Plus Chemotherapy for Advanced Gastric Cancer with Programmed Death-Ligand 1 Expression ≥ 1%: A Retrospective Analysis of RATIONALE-305Markus Moehler, Do-Youn Oh, Ken Kato, et al.
Pageof 457